Last Price
1.21
Today's Change
-0.06 (4.72%)
Day's Change
1.20 - 1.25
Trading Volume
118,160
Exchange: Australian Securities Exchange Australian Securities Exchange
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Steven Wedan Mr. Steven Wedan
Full Time Employees: 0 0
IPO Date: 2019-08-30 2019-08-30
ISIN: AU0000054942 AU0000054942
Beta: 0.25 0.25
Last Dividend: 0.00 0.00
Dcf Diff: 1.58 1.58
Dcf: -0.37 -0.37
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.